bungarus multicinctus-candidus antivenom
Biologicalexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2004 (NCT00811239)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Bungarus multicinctusImmunity, passive
Bungarus multicinctus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bungarus multicinctus-candidus antivenom
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00811239 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2004 | Government of Sweden, Hanoi Medical University, Karolinska Institute |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Sweden | Government | 1 | 0 | 1 | 2004 |
| Hanoi Medical University | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Karolinska Institute | Academic/Hospital | 1 | 0 | 1 | 2004 |
3 organizations
Page 1 / 1